All News

Dr McDermott @jeffsparks on risk factors for RA-bronchiectasis. Seropositivity, older age at RA onset, and lower BMI⬆️risk. Abstr#0288 #ACR21 @RheumNow https://t.co/7d2ZVWLzn6
Richard Conway RichardPAConway ( View Tweet)
#ACR21 Great Debate: Voclosporin vs Tacro? ⭐️Voclosporin has carbon bond extension, changing how voclosporin binds to calcineurin. ⭐️Consistent dose-response prevents need for drug monitoring ⭐️Increases potency and results in improved metabolic profile @Rheumnow https://t.co/cY93st7754
Eric Dein ericdeinmd ( View Tweet)
This is an important slide showing how belimumab protected the GFR... ultimately the reason why we are treating #lupus nephritis patients - Prof Michelle Petri @RheumNow #ACR21 #rheumatology 📌https://t.co/bO3ubqY2bf https://t.co/yuqwlKXDBH

Links:

sheila RHEUMarampa ( View Tweet)
#ACR21 Abs#0101 on recombinant #zoster vaccine (RZV) in #IMIDs: •High proportion of ≥50yos w/ IMIDs received RZV but 15–25% did not get 2nd dose within 6m •#Vaccination higher in ≥65yos than 50–64yos •Need better vaccine policy to encourage uptake in pts w/ IMIDs @RheumNow https://t.co/i5JDJClTyQ
Mrinalini Dey DrMiniDey ( View Tweet)
@jhrheumatology data on ESRD in Lupus Nephritis, Dr. Michelle Petri. #ACR21 Debate ▶️ 20% risk of renal failure in 20 years is way too high ▶️ C3 strongest predictor, dsDNA also seen ⭐️⬇️ complement, ⬆️dsDNA in lupus nephritis suggests Belimumab is good agent for LN @Rheumnow https://t.co/ewLAxMgTT0
Eric Dein ericdeinmd ( View Tweet)
#ACR21 @RheumNow Abst#0359 by Garrido-Cumbrera et al. has mapped out the journey from symptom onset to diagnosis of axSpA across 13 European countries.

swethaann23 swethaann23 ( View Tweet)

Before the Great Debate: Next step for Lupus Nephritis? #ACR21 @Rheumnow

Eric Dein ericdeinmd ( View Tweet)

Abstract 0095 Barbhiaya et al examined risk factors for 'Long Haul' COVID-19 in Rheumatology Outpatients in NYC #ACR21 @RheumNow

Akhil Sood MD AkhilSoodMD ( View Tweet)

Phase 2 German study demonstrates superiority of TCZ vs PBO in FMF. SAA levels only normalized in TCZ treated patients. Interesting concept that needs to be replicated in larger trials. Abs 0193 #ACR21 #RheumNow @RheumNow https://t.co/awqOpwg3gH https://t.co/lGzYglnkyM

Links:

Dr. Rachel Tate uptoTate ( View Tweet)
Abst0242 #ACR21 @RheumNow FROST: 1st line Rx of SJIA 73 pts. two study arms: biologics & GC/MTX arm. In biologic arm 14% IL-1i switched to IL-6i, 0% from IL-6i to IL-1i. 50%GC/MTX eventually initiated biologic therapy . 57% of pts d/cGC use, and 75% had cJADAS-10 score ≤ 2.5 https://t.co/vH0AnocTr2
Olga Petryna DrPetryna ( View Tweet)
Data science for the dumbs. Very informative talk from Dr Jamie Collins! Surely helpful for me. A good way to decide on the best supervised methods for data analysis in machine learning is to separate according to our goal: to explain or to predict? #ACR2021 @RheumNow https://t.co/J0j6VMkoTV
Aurelie Najm AurelieRheumo ( View Tweet)
#ACR21 2nd abstract #0381 from #DESIR cohort by @ElenaNikiUK: •High disease activity & decreased function assoc w/ greater #WorkDisability •Not enough to just treat the disease! Need holistic approaches to improve function, QoL & work outcomes. @RheumNow https://t.co/jIs3Oj7nbJ

Links:

Mrinalini Dey DrMiniDey ( View Tweet)

Completely new one for me, Dr Taniguchi presenting on using ear ultrasound to diagnose and monitor disease activity in relapsing polychondritis. Appears useful, I suspect in clinical practice more so for diagnosis. Abstr#0169 #ACR21 @RheumNow https://t.co/PLJtkYkP3A
Richard Conway RichardPAConway ( View Tweet)
@jhrheumatology Dr. Petri at #ACR21 Great Debate. Safety issues with Voclosporin: 1) Nephrotoxicity 2) Infection 3) CV Risk Factors 4) Malignancy 5) Neurologic toxicity 6) Osteoporosis 7) Drug interactions 8) Deaths 9) Pregnancy contraindication @RheumNow https://t.co/wjluivmKNt
Eric Dein ericdeinmd ( View Tweet)
#ClinicalPearl. Pts have no preference btwn phone or video telemedicine. You can get calls more easily in PJs, technology of internet may be difficult for elderly, hearing impaired & rural with poor internet bandwidth so I would’ve guessed phone was preferred @RheumNow #abst0112 https://t.co/1F4HH9nXB8

Links:

Janet Pope Janetbirdope ( View Tweet)

RheumNow’s expanded coverage of #ACR21 is sponsored in part by @Novartis. All content chosen by RheumNow & its Faculty.

Dr. John Cush RheumNow ( View Tweet)

Is holding MTX during breastfeeding overblown? @MotherToBaby data showed that infants get 0.4% of mom’s dose 24 hrs post-MTX dose. Skip breastfeeding 1 day post-MTX may be safe. Consider monitoring infant CBC. Studies needed to follow infants longitudinally #ACR21 @rheumnow https://t.co/ikJvkk5BjI
TheDaoIndex KDAO2011 ( View Tweet)
#ACR21 Abst#0170: ↑ epicardial adipose tissue volume predicts new coronary plaque development in the following RA patients: ⋆ <10 yrs dz (OR 5.75) ⋆ 1 cardiac risk (OR 3.4) ⋆ statin < 1 yr (OR 3.3) ⋆ w/o calcification at b/l (OR 2.65) @Rheumnow https://t.co/tnyWRVSger https://t.co/uhak4kdbll

Links:

Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
Interesting study on 5yr CV event risk in early #rheumatoidarthritis pts who received T2T mgt shows no difference in CVE risk in ERA grp vs control ERA cohort: > Longer remission = protective for CVE > ⬆ HAQ = predictive of CVE Tighter control, ⬇ CVEs @RheumNow #ACR21 abs0282 https://t.co/GG7HPvWd0r
sheila RHEUMarampa ( View Tweet)
Excited for the first full day of #ACR21, reporting for @RheumNow! Esp looking forward to: ⭐Posters: #Epidemiology, #PublicHealth, #COVID19, #SpA, #RheumatoidArthritis, #PatientOutcomes ⭐Plenary session ⭐Scientific sessions covering #axSpA, #PsA and more

Mrinalini Dey DrMiniDey ( View Tweet)

×